» Articles » PMID: 38543914

Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design

Overview
Date 2024 Mar 28
PMID 38543914
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are small subtypes of extracellular vesicles (EVs) naturally released by different types of cells into their environment. Their physiological roles appear to be multiple, yet many aspects of their biological activities remain to be understood. These vesicles can transport and deliver a variety of cargoes and may serve as unconventional secretory vesicles. Thus, they play a crucial role as important vectors for intercellular communication and the maintenance of homeostasis. Exosome production and content can vary under several stresses or modifications in the cell microenvironment, influencing cellular responses and stimulating immunity. During infectious processes, exosomes are described as double-edged swords, displaying both beneficial and detrimental effects. Owing to their tractability, the analysis of EVs from multiple biofluids has become a booming tool for monitoring various pathologies, from infectious to cancerous origins. In this review, we present an overview of exosome features and discuss their particular and ambiguous functions in infectious contexts. We then focus on their properties as diagnostic or therapeutic tools. In this regard, we explore the capacity of exosomes to vectorize immunogenic viral antigens and their function in mounting adaptive immune responses. As exosomes provide interesting platforms for antigen presentation, we further review the available data on exosome engineering, which enables peptides of interest to be exposed at their surface. In the light of all these data, exosomes are emerging as promising avenues for vaccine strategies.

Citing Articles

A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection.

Tripathi A, Chauhan S, Khasa R Viruses. 2025; 17(1).

PMID: 39861863 PMC: 11769230. DOI: 10.3390/v17010074.


Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration.

Rayat Pisheh H, Sani M Stem Cell Res Ther. 2025; 16(1):16.

PMID: 39849585 PMC: 11756228. DOI: 10.1186/s13287-024-04123-2.


Oncoviral Infections and Small Extracellular Vesicles.

Wazny L, Whiteside T, Pietrowska M Viruses. 2024; 16(8).

PMID: 39205265 PMC: 11359865. DOI: 10.3390/v16081291.


Exosomes: the next frontier in vaccine development and delivery.

Tan D, Li G, Fu W, Lei C Front Immunol. 2024; 15:1435426.

PMID: 39007145 PMC: 11239336. DOI: 10.3389/fimmu.2024.1435426.


Exosome may be the next generation of promising cell-free vaccines.

Dai Z, Cai R, Zeng H, Zhu H, Dou Y, Sun S Hum Vaccin Immunother. 2024; 20(1):2345940.

PMID: 38714324 PMC: 11086043. DOI: 10.1080/21645515.2024.2345940.

References
1.
Rivera-Cuevas Y, Carruthers V . The multifaceted interactions between pathogens and host ESCRT machinery. PLoS Pathog. 2023; 19(5):e1011344. PMC: 10159163. DOI: 10.1371/journal.ppat.1011344. View

2.
Bliss C, Parsons A, Nachbagauer R, Hamilton J, Cappuccini F, Ulaszewska M . Targeting Antigen to the Surface of EVs Improves the Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice. Mol Ther Methods Clin Dev. 2020; 16:108-125. PMC: 6953706. DOI: 10.1016/j.omtm.2019.12.003. View

3.
Maas S, Breakefield X, Weaver A . Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol. 2016; 27(3):172-188. PMC: 5318253. DOI: 10.1016/j.tcb.2016.11.003. View

4.
Li J, Wei L, Han Z, Chen Z . Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019; 852:68-76. DOI: 10.1016/j.ejphar.2019.01.022. View

5.
Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T . Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165(2):77-84. DOI: 10.1016/j.jbiotec.2013.03.013. View